Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 6 of 6  Show
  1. 16
    "SOX9 and SOX10 but not BRN2 are required for nestin expression in human melanoma cells."
    Flammiger A., Besch R., Cook A.L., Maier T., Sturm R.A., Berking C.
    J. Invest. Dermatol. 129:945-953(2009) [PubMed] [Europe PMC] [Abstract]
    Category: Expression.
    Annotation: SOX9 and SOX10 but not BRN2 seem to be required for nestin expression in human melanoma.
    Source: GeneRIF:5454.

    This publication is mapped to 22 other entries.

  2. 22
    "Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor."
    Boyle G.M., Woods S.L., Bonazzi V.F., Stark M.S., Hacker E., Aoude L.G., Dutton-Regester K., Cook A.L., Sturm R.A., Hayward N.K.
    Pigment Cell Melanoma Res 24:525-537(2011) [PubMed] [Europe PMC] [Abstract]
    Category: Expression.
    Annotation: a model for the apparent non-overlapping expression levels of BRN2 and MITF in melanoma mediated by miR-211 expression.
    Source: GeneRIF:5454.

    This publication is mapped to 1 other entry.

  3. 25
    "Neural lineage-specific homeoprotein BRN2 is directly involved in TTF1 expression in small-cell lung cancer."
    Sakaeda M., Sato H., Ishii J., Miyata C., Kamma H., Shishido-Hara Y., Shimoyamada H., Fujiwara M., Endo T., Tanaka R., Kondo H., Goya T., Aoki I., Yazawa T.
    Lab. Invest. 93:408-421(2013) [PubMed] [Europe PMC] [Abstract]
    Category: Expression.
    Annotation: TTF1 expression in small-cell lung cancer is a cell lineage-specific phenomenon that involves the developing neural cell-specific homeoprotein BRN2.
    Source: GeneRIF:5454.

    This publication is mapped to 4 other entries.

  4. 26
    "POU domain transcription factor BRN2 is crucial for expression of ASCL1, ND1 and neuroendocrine marker molecules and cell growth in small cell lung cancer."
    Ishii J., Sato H., Sakaeda M., Shishido-Hara Y., Hiramatsu C., Kamma H., Shimoyamada H., Fujiwara M., Endo T., Aoki I., Yazawa T.
    Pathol. Int. 63:158-168(2013) [PubMed] [Europe PMC] [Abstract]
    Category: Function, Expression.
    Annotation: BRN2 is a higher level regulator than ASCL1 and ND1 and BRN2 might be involved in aggressiveness of small cell lung cancer.
    Source: GeneRIF:5454.

    This publication is mapped to 2 other entries.

  5. 32
    "NTF3 Is a Novel Target Gene of the Transcription Factor POU3F2 and Is Required for Neuronal Differentiation."
    Lin Y.J., Hsin I.L., Sun H.S., Lin S., Lai Y.L., Chen H.Y., Chen T.Y., Chen Y.P., Shen Y.T., Wu H.M.
    Mol. Neurobiol. 55:8403-8413(2018) [PubMed] [Europe PMC] [Abstract]
    Category: Function, Pathology & Biotech, Expression.
    Annotation: NTF3 is a novel target gene of POU3F2 and that the POU3F2/NTF3 pathway plays a role in the process of neuronal differentiation.
    Source: GeneRIF:5454.

    This publication is mapped to 6 other entries.

  6. 34
    Category: Function, Expression, Interaction.
    Annotation: BRN2 also suppresses an apoptosis-associated gene expression program to protect against UVB- chemotherapy- and vemurafenib-induced apoptosis. Remarkably BRN2 expression also correlates with a high single-nucleotide variation prevalence in human melanomas.
    Source: GeneRIF:5454.

    This publication is mapped to 1 other entry.

1 to 6 of 6  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again